Lifecore Biomedical share price logo

Lifecore Biomedical

NASDAQ: LFCR

$6.38

-0.06

(-0.93%)

as on

Lifecore Biomedical Stock Performance

as on October 17, 2026 at 2:16 pm IST

  • Day's High

    $6.38
    $6.43

    0.78%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.63
    $8.98
    downward going graph

    43.18%

    Downside

    40.75%

    Upside

    downward going graph

Lifecore Biomedical share price movements today

Previous Close
$6.44
Open
$6.43
Volume
1.9M
Market Cap
$244.1M
Day's Low - High
$6.38 - $6.43
52 Week Low - High
$3.63 - $8.98

Lifecore Biomedical Historical Returns

1 Month Return
+ 43.05 %
3 Month Return
+ 36.32 %
1 Year Return
-1.69 %
3 Year Return
-12.84 %
5 Year Return
0 %

Lifecore Biomedical Stock Fundamentals & Key Indicators

Check Lifecore Biomedical market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$244.1M

EPS (TTM)

-0.81

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.85

Industry PE ratio

-8.60

PEG Ratio

0.47

EBITDA

3.0M

Revenue (TTM)

91.5M

Profit Margin

29.68%

Return On Equity TTM

-376.95%

Lifecore Biomedical vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lifecore Biomedical with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Neutral$244.1MNA-5.8529.68%0.00%
Buy$39.3BNA61.0147.54%1.13%
Buy$23.2B184.98%17.9186.14%0.00%
Buy$20.0B38.60%-50.6134.83%2.63%
Buy$42.3BNA20.6665.57%1.99%

Stock Returns calculator for Lifecore Biomedical Stock including INR - Dollar returns

The Lifecore Biomedical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Lifecore Biomedical investment value today

Current value as on today

₹1,06,092

Returns

₹6,092

(+6.09%)

Returns from Lifecore Biomedical Stock

-₹1,695 (-1.69%)

Dollar Impact

₹7,786 (+7.79%)

Analyst Recommendation on Lifecore Biomedical Stock

Based on 4 analysts

HOLD

0.00%

Buy

100.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'HOLD' rating for Lifecore Biomedical. Average target price of $6.28

Lifecore Biomedical Share Price Target

Get share price movements and forecasts by analysts on Lifecore Biomedical.

What analysts predicted

-1.59%DOWNSIDE

Target Price

$6.28

Current Price

$6.38

Analyzed by

4 Analysts

High

$6.28

Target

$6.28

Low

$6.28

Lifecore Biomedical target price $6.28, a slight downside of -1.59% compared to current price of $6.38. According to 4 analysts rating.

Indian Investors' Interest in Lifecore Biomedical Stock

Search interest for Lifecore Biomedical Stock has increased by 1786% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1786% versus previous 30 day period

Lifecore Biomedical Quarterly Profit & Loss

All numbers in Millions USD

Feb 2024
May 2024
Aug 2024
Nov 2024
Feb 2025
May 2025
Aug 2025
Dec 2025
Mar 2026
Dec 2026
Total Revenue
35
37
24
32
35
36
31
34
23
34
Gross Profit
11
17
5
11
9
13
7
12
4
12
Operating Income
0
2
-11
-1
-9
5
-3
2
-4
2
EBITDA
21
0
-8
0
-7
6
-7
4
-5
4
Interest Expense
4
5
5
5
5
5
6
7
7
7
Depreciation
2
2
1
2
2
1
1
2
2
2
Income Before Tax
15
-7
-16
-6
-14
-1
-9
-6
-14
-6
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
15
-7
-16
-6
-14
-1
-9
-6
-14
-6
Net Profit Margin
33.31%
45.59%
21.81%
34.04%
28.01%
38.37%
25.04%
35.34%
19.24%
35.34%

Lifecore Biomedical Annual Profit & Loss

All numbers in Millions USD

May 2017
May 2018
May 2019
May 2020
May 2021
May 2022
Aug 2023
May 2024
May 2025
Dec 2025
Total Revenue
532
524
557
160
100
111
103
128
128
129
Gross Profit
83
78
81
39
38
39
27
41
40
40
Operating Income
15
11
-8
-25
-8
-11
-21
-8
-17
-1
EBITDA
26
25
24
-7
0
12
-33
35
-8
8
Interest Expense
1
1
5
4
8
15
17
18
21
-2
Depreciation
10
12
15
18
19
18
13
7
8
9
Income Before Tax
15
16
3
-30
-29
-20
-63
9
-38
-30
Income Tax Expense
4
-9
1
-8
-6
-5
0
0
0
0
Net Income
10
24
2
-38
-32
-116
-99
12
-38
-30
Net Profit Margin
15.63%
14.94%
14.53%
24.61%
38.60%
35.11%
27.10%
32.63%
31.27%
31.37%

Lifecore Biomedical Quarterly Cash Flow

All numbers in Millions USD

Feb 2024
May 2024
Aug 2024
Nov 2024
Feb 2025
May 2025
Aug 2025
Dec 2025
Mar 2026
Dec 2026
Net Income
15
-7
-16
-6
-14
-1
-9
-6
-14
2
Operating Cash Flow
-1
8
0
-6
1
5
1
-2
4
0
Investing Cash Flow
-6
-2
-3
-2
1
-2
-1
9
-1
5
Financing Cash Flow
7
0
1
12
-6
0
-1
-3
0
-2
Change in Cash
0
5
-2
3
-4
2
-1
7
3
15

Lifecore Biomedical Annual Cash Flow

All numbers in Millions USD

May 2017
May 2018
May 2019
May 2020
May 2021
May 2022
Aug 2023
May 2024
May 2025
Dec 2025
Net Income
10
24
0
-15
-32
-116
-99
12
-38
-31
Operating Cash Flow
29
19
16
-17
16
-22
-17
0
0
12
Investing Cash Flow
-25
-35
-96
-23
-12
79
-4
-18
-6
-1
Financing Cash Flow
-8
13
79
40
-3
-57
39
7
6
-1
Change in Cash
-4
-2
-1
0
0
0
17
-10
0
0

Global Institutional Holdings in Lifecore Biomedical

Check out the Institutions with significant holdings in Lifecore Biomedical.

Funds
Holdings
Christopher Kiper
11.77%
Scott Miller
8.42%
Vanguard
3.82%
VANGUARD INDEX FUNDS
3.32%
iShares
3.05%

Lifecore Biomedical News & Key Events

  • img

    Today's Timeline - 28 September

    Mon, 06:20 PM

    -

    Lifecore Biomedical agrees to be acquired by Webster Equity Partners for $6.28 per share, valuing the deal at up to $663.7M.

Insights on Lifecore Biomedical

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -14.97M → -6.15M (in $), with an average increase of 143.3% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, LFCR stock has moved up by 43.0%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 23.19M → 34.16M (in $), with an average increase of 32.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 97.8% return, outperforming this stock by 110.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 83.4% return, outperforming this stock by 85.1%

About Lifecore Biomedical

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
OrganisationLifecore Biomedical
Headquarters3515 Lyman Boulevard, Chaska, MN, 55318, US
IndustryDrug Manufacturers - Specialty & Generic
CEOPaul Josephs

Key Management of Lifecore Biomedical

Name

Title

Mr. Parker K. Javid

Vice President

Mr. Paul Josephs

President, CEO & Director

Mr. Ryan D. Lake CPA

Executive VP & CFO

Mr. Thomas D. Salus

Chief Legal & Administration Officer and Corporate Secretary

Mr. Thomas Guldager

Vice President of Operations

Mr. Aaron Perlitsh

Director of Internal Audit & Chief Compliance Officer

Ms. Jackie Q. Klecker

Executive Vice President of Quality & Development Services

Mr. Mark DaFonseca

Chief Commercial Officer

FAQs

What is Lifecore Biomedical share price today?

Lifecore Biomedical share price today is $6.38 as on at the close of the market. Lifecore Biomedical share today touched a day high of $6.43 and a low of $6.38.

What is the 52 week high and 52 week low for Lifecore Biomedical share?

Lifecore Biomedical share touched a 52 week high of $8.98 on and a 52 week low of $3.63 on . Lifecore Biomedical stock price today i.e. is closed at $6.38,which is 28.95% down from its 52 week high and 76.00% up from its 52 week low.

What is Lifecore Biomedical's market capitalisation today?

Lifecore Biomedical market capitalisation is $0.00T as on .

How to invest in Lifecore Biomedical Stock (LFCR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lifecore Biomedical on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Lifecore Biomedical Stock (LFCR) from India?

Indian investors can start investing in Lifecore Biomedical (LFCR) shares with as little as ₹94.95999908447266 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Lifecore Biomedical stock (as per the Rupee-Dollar exchange rate as on ). Based on Lifecore Biomedical share’s latest price of $6.38 as on October 17, 2026 at 8:46 am IST, you will get 1.5674 shares of Lifecore Biomedical. Learn more about fractional shares .